Under bankruptcy, owners and financials
CVR: 36474483
Not available
Net result: EUR -84,833,635
IO Biotech Inc. (100%)
CVR · view owners
No current management
CVR · view management
Under bankruptcy
Founded 23 December 2014
CVR · view overview
9 employees
CVR · 2026
Director role ended: Mai-Britt Zocca
CVR · 08/04/2026
View the full event history
IO BIOTECH ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2014. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by IO Biotech Inc.. The company has 9 employees (2026). In 2024, the company reported a net result of EUR -84,833,635 compared with EUR -76,648,917 the year before. Equity in the 2024 report amounted to EUR -6,630,183.
Selskabets formål er udvikling af en vaccine rettet imod immumhæmmende celler alt med henblik på forebyggelse og/eller behandling af cancer, samt hermed efter bestyrelsens skøn beslægtede formål.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | - | -84.8M EUR | 67M EUR | -6.6M EUR | 25 | |
| 202301/01/2023 – 31/12/2023 | - | -76.6M EUR | 59M EUR | 18.2M EUR | 21 | |
| 202201/01/2022 – 31/12/2022 | - | -463M | 417M | 259.7M | 19 | |
| 202101/01/2021 – 31/12/2021 | - | -240.4M | 803.1M | 722.8M | 15 | |
| 202001/01/2020 – 31/12/2020 | - | -65.2M | 36.1M | 17.5M | - | |
| 201901/01/2019 – 31/12/2019 | - | -68.7M | 63.2M | -13.9M | 12 | |
| 201801/01/2018 – 31/12/2018 | - | -51.3M | 63.8M | 54.8M | 11 | |
| 201701/01/2017 – 31/12/2017 | - | -25.1M | 49.6M | 44.3M | 6 | |
| 201601/01/2016 – 31/12/2016 | - | -12.3M | 73.7M | 69.4M | 5 | |
| 201523/12/2014 – 31/12/2015 | - | -3.2M | 20M | 18.6M | - |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Indkaldelse til fordringsprøvelse i konkursboet IO BIOTECH ApS, Sø- og Handelsretten, sagsnr. K 757/26-F.
Ved dekret af 8. april 2026 har Sø- og Handelsrettens skifteret taget IO BIOTECH ApS under konkursbehandling. Kurator: Advokat Michala Roepstorff, Amerika Plads 37, 2100 København Ø. Sagsnr. K 757/26-F.
Source: Statstidende, updated daily
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationYes. IO BIOTECH ApS is registered in the Danish CVR register with the status under bankruptcy. The bankruptcy decree is published in Statstidende.
The CVR number of IO BIOTECH ApS is 36474483.
IO BIOTECH ApS is owned by IO Biotech Inc..
IO BIOTECH ApS had 9 employees in 2026 according to the Danish CVR register.
IO BIOTECH ApS was founded on 23 December 2014.
IO BIOTECH ApS was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
On October 12, 2026, IO BIOTECH ApS was placed under bankruptcy proceedings.
Contact info changed: new email: [email protected] (May 7, 2026).
On May 5, 2026, a notice regarding IO BIOTECH ApS was published in Statstidende: Indkaldelse til fordringsprøvelse (S01052026-257).
Contact info changed: new email: [email protected] (April 12, 2026).
On April 10, 2026, a notice regarding IO BIOTECH ApS was published in Statstidende: Konkursdekret (S08042026-38).
As of April 8, 2026, EY Godkendt Revisionspartnerselskab has stepped down as auditor of IO BIOTECH ApS.
As of April 8, 2026, Mai-Britt Zocca has stepped down as adm. dir. of IO BIOTECH ApS.
IO BIOTECH ApS has published its annual report for 2024. The net result was DKK -84,833,635.
IO BIOTECH ApS has published its annual report for 2023. The net result was DKK -76,648,917.
IO BIOTECH ApS has published its annual report for 2022. The net result was DKK -463,037,029.
As of November 15, 2022, Christian Ellebæk Elling has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Jack Bech Nielsen has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Peter Hirth has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Kathleen Sereda Glaub has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Priyanka Belawat has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Vanessa Malier has left the board of directors of IO BIOTECH ApS.
IO BIOTECH ApS has published its annual report for 2021. The net result was DKK -240,410,969.
As of May 25, 2022, Claus Asbjørn Andersson has left the board of directors of IO BIOTECH ApS.
As of May 25, 2022, Emmanuelle Coutanceau has left the board of directors of IO BIOTECH ApS.
As of October 29, 2021, is registered as an owner of IO BIOTECH ApS with an ownership share of 100%.
IO BIOTECH ApS has published its annual report for 2020. The net result was DKK -65,160,755.
As of January 15, 2021, Jack Bech Nielsen has joined the board of directors of IO BIOTECH ApS.
As of January 15, 2021, Priyanka Belawat has joined the board of directors of IO BIOTECH ApS.
As of January 15, 2021, Vanessa Malier has joined the board of directors of IO BIOTECH ApS.
As of January 15, 2021, Mads Hald Andersen has left the board of directors of IO BIOTECH ApS.
IO BIOTECH ApS has published its annual report for 2019. The net result was DKK -68,677,061.
As of October 1, 2019, Emmanuelle Coutanceau has joined the board of directors of IO BIOTECH ApS.
As of October 1, 2019, Stephan Christgau has left the board of directors of IO BIOTECH ApS.
IO BIOTECH ApS has published its annual report for 2018. The net result was DKK -51,326,887.
IO BIOTECH ApS has published its annual report for 2017. The net result was DKK -25,107,554.
As of May 4, 2018, Kathleen Sereda Glaub has joined the board of directors of IO BIOTECH ApS.
IO BIOTECH ApS has published its annual report for 2016. The net result was DKK -12,322,483.
As of December 15, 2016, Claus Asbjørn Andersson has joined the board of directors of IO BIOTECH ApS.
As of September 21, 2016, Peter Hirth has joined the board of directors of IO BIOTECH ApS.
As of September 21, 2016, Hans Thalsgård Schambye has left the board of directors of IO BIOTECH ApS.
IO BIOTECH ApS has published its annual report for 2015. The net result was DKK -3,249,660.
As of December 18, 2015, Christian Ellebæk Elling has joined the board of directors of IO BIOTECH ApS.
As of December 18, 2015, Stephan Christgau has joined the board of directors of IO BIOTECH ApS.
As of December 18, 2015, Nanna Liebach Lüneborg has left the board of directors of IO BIOTECH ApS.
As of December 14, 2015, EY Godkendt Revisionspartnerselskab has been appointed auditor of IO BIOTECH ApS.
As of January 7, 2015, Hans Thalsgård Schambye has joined the board of directors of IO BIOTECH ApS.
As of January 7, 2015, Mads Hald Andersen has joined the board of directors of IO BIOTECH ApS.
As of January 7, 2015, Nanna Liebach Lüneborg has joined the board of directors of IO BIOTECH ApS.
As of January 7, 2015, Bo Anders Ljungqvist has left the board of directors of IO BIOTECH ApS.
As of January 7, 2015, Mai-Britt Zocca has left the board of directors of IO BIOTECH ApS.
As of December 23, 2014, Bo Anders Ljungqvist has joined the board of directors of IO BIOTECH ApS.
As of December 23, 2014, Mai-Britt Zocca has joined the board of directors of IO BIOTECH ApS.
As of December 23, 2014, Mai-Britt Zocca is registered as adm. dir. of IO BIOTECH ApS.
IO BIOTECH ApS was founded on December 23, 2014.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
